Screener
10x Genomics, Inc. TXG Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $20,694 | $12,733 |
| Accrued compensation and related benefits | 24,744 | 42,500 |
| Accrued expenses and other current liabilities | 30,377 | 39,971 |
| Deferred revenue | 23,610 | 23,902 |
| Operating lease liabilities | 12,015 | 10,985 |
| Contingent consideration, current | 7,069 | 23,363 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s accrued expenses?
- 10x Genomics, Inc. (TXG) reported accrued expenses of $24.74M in Q2 2026.
- How has 10x Genomics, Inc.'s accrued expenses changed year-over-year?
- 10x Genomics, Inc.'s accrued expenses decreased by 5.2% year-over-year, from $26.1M to $24.74M.
- What is the long-term trend for 10x Genomics, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s accrued expenses has grown at a 22.5% compound annual growth rate (CAGR), from $15.38M to $42.5M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about 10x Genomics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude